Skip to main content
Log in

Effect of electroacupuncture on anti-Mullerian hormone expression in rats with polycystic ovarian syndrome

电针对多囊卵巢综合征大鼠抗苗勒氏管激素水平的影响

  • Basic Study
  • Published:
Journal of Acupuncture and Tuina Science Aims and scope Submit manuscript

Abstract

Objective

To observe whether the effect of electroacupuncture (EA) on improving sex hormone disorders and follicle development is by decreasing the expression of anti-Mullerian hormone (AMH) in rats with experimental polycystic ovarian syndrome (PCOS).

Methods

Forty rats were randomly divided into four groups, a normal group (NG), a model group (MG), an EA at acupoints group (EAAG), and an EA at non-acupoints group (EANAG), with 10 rats in each group. The rats in the EAAG and EANAG were intervened by EA treatment for consecutive 14 d. Zhongji (CV 3) and Guanyuan (CV 4) were selected as the acupoints in the EAAG, and the tip of the tail and 1 cm up from the tail tip were selected as the non-acupoints in the EANAG. After treatment, the histomorphological changes of the ovary, the levels of aromatase P450 (P450arom), testosterone and estradiol in the ovarian tissues, and the expressions of follicle stimulating hormone (FSH) and AMH were observed.

Results

After treatment, compared with the MG and EANAG, the expression of AMH decreased (P<0.05), the levels of P450arom and estradiol increased significantly, and the level of testosterone decreased significantly (all P<0.01) in the EAAG. Additionally, several normal follicles were present and the number of cystically dilated follicles decreased in the EAAG. Compared with the MG and EANAG, the EAAG obviously had more follicular granulosa cells.

Conclusion

EA can down-regulate the abnormally increased expression of AMH to improve sex hormone disorders and follicle development in PCOS rats.

概要

目的

观察电针是否通过降低抗苗勒氏管激素(AMH)的表达实现对多囊卵巢综合征(PCOS)大鼠性激素紊乱和卵泡发育障碍的改善作用。

方法

将 40 只大鼠随机分为正常组、 模型组、 电针经穴组和电针非经穴组, 每组 10 只。 电针经穴组和电针非经穴组大鼠连续治疗 14 d。 电针经穴组大鼠取中极和关元; 电针非经穴组取尾尖和尾尖上 1 cm 处。 观察治疗后卵巢组织形态学变化, P450 芳香化酶、 睾酮和雌二醇水平以及促卵泡生成素(FSH)和AMH的表达。

结果

同模型组和电针非经穴组比较, 电针经穴组 AMH 表达降低(P<0.05), P450 芳香化酶和雌二 醇水平显著升高, 睾酮水平显著降低(均P<0.01)。 此外, 电针经穴组存在数个正常卵泡, 囊性扩张卵泡减少, 卵泡颗粒细胞数明显多于模型组和电针非经穴组。

结论

电针可下调 PCOS 大鼠 AMH 的异常过度表达, 从而改善性激素紊乱和卵泡发育障碍。

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rutkowska AZ, Diamanti-Kandarakis E. Polycystic ovary syndrome and environmental toxins. Fertil Steril, 2016, 106(4): 948–958.

    Article  CAS  PubMed  Google Scholar 

  2. Zhou Z, Li R, Qiao J. Androgen profile in Chinese women with polycystic ovary syndrome in their reproductive years. Reprod Biomed Online, 2017, 35(3): 331–339.

    Article  CAS  PubMed  Google Scholar 

  3. Hakim C, Padmanabhan V, Vyas AK. Gestational hyperandrogenism in developmental programming. Endocrinology, 2017, 158(2): 199–212.

    Article  PubMed  Google Scholar 

  4. Simon V, Avet C, Grange-Messent V, Wargnier R, Denoyelle C, Pierre A, Dairou J, Dupret JM, Cohen-Tannoudji J. Carbon black nanoparticles inhibit aromatase expression and estradiol secretion in human granulosa cells through the ERK1/2 pathway. Endocrinology, 2017, 158(10): 3200–3211.

    Article  PubMed  Google Scholar 

  5. Sacchi S, D'lppolito G, Sena P, Marsella T, Tagliasacchi D, Maggi E, Argento C, Tirelli A, Giulini S, La Marca A. The anti-Mullerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH. J Assist Reprod Genet, 2016, 33(1): 95–100.

    Article  PubMed  Google Scholar 

  6. Dumont A, Robin G, Catteu-Jonard S, Dewailly D. Role of anti-Mullerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review. Reprod Biol Endocrinol, 2015, 13: 137.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gorsic LK, Kosova G, Werstein B, Sisk R, Legro RS, Hayes MG, Teixeira JM, Dunaif A, Urbanek M. Pathogenic anti-Mullerian hormone variants in polycystic ovary syndrome. J Clin Endocrinol Metab, 2017, 102(8): 2862–2872.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Garg D, Tal R. The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod Biomed Online, 2016, 33(1): 15–28.

    Article  CAS  PubMed  Google Scholar 

  9. Dewailly D, Robin G, Peigne M, Decanter C, Pigny P, Catteau-Jonard S. Interactions between androgens, FSH, anti-Mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update, 2016, 22(6): 709–724.

    Article  CAS  PubMed  Google Scholar 

  10. Prapa E. Effect of anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling. J Assist Reprod Genet, 2015, 32(7): 1079–1088.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Yu L, Cao L, Xie J, Shi Y. Therapeutic effects on ovulation and reproduction promotion with acupuncture and clomiphene in polycystic ovary syndrome. Zhongguo Zhen Jiu, 2018, 38(3): 263–268.

    PubMed  Google Scholar 

  12. Zhan JM, Wang HM. Observation on therapeutic effects of electroacupuncture for obesity polycystic ovary syndrome. J Acupunct Tuina Sci, 2008, 6(2): 90–93.

    Article  Google Scholar 

  13. Feng Y, Johansson J, Shao R, Holm LM. Electrical and manual acupuncture stimulation affect oestrous cyclicity and neuroendocrine function in a 5α-dihydrotestosteroneinduced rat polycystic ovary syndrome model. Exp Physiol, 2012, 97(5): 651–662.

    Article  CAS  PubMed  Google Scholar 

  14. Maliqueo M, Benrick A, Alvi A, Johansson J, Sun M, Labrie F, Ohlsson C, Stener-Victorin E. Circulating gonadotropins and ovarian adiponectin system are modulated by acupuncture independently of sex steroid or beta-adrenergic action in a female hyperandrogenic rat model of polycystic ovary syndrome. Mol Cell Endocrinol, 2015, 412: 159–169.

    Article  CAS  PubMed  Google Scholar 

  15. Feng Y, Johansson J, Shao R, Mannerås L, Fernandez-Rodriguez J, Billig H, Stener-Victorin E. Hypothalamic neuroendocrine functions in rats with dihydrotestosteroneinduced polycystic ovary syndrome: effects of lowfrequency electroacupuncture. PLoS One, 2009, 4(8): e6638.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Li J, Cui W, Sun W, Zhang QY, Guan Q. Effect of electroacupuncture intervention on spindle body and oocytes quality in patients with polycystic ovary syndrome. Zhongguo Zhongxiyi Jiehe Zazhi, 2015, 35(3): 304–309.

    PubMed  Google Scholar 

  17. Sun J, Zhao JM, Ji R, Liu HR, Shi Y, Jin CL. Effects of electroacupuncture of ‘Guanyuan’ (CV 4)-‘Zhongji’ (CV 3) on ovarian P450arom and P450c17α expression and relevant sex hormone levels in rats with polycystic ovary syndrome. Zhen Ci Yan Jiu, 2013, 38(6): 465–472.

    CAS  PubMed  Google Scholar 

  18. Sun J, Jin C, Wu H, Zhao J, Cui Y, Liu H, Wu L, Shi Y, Zhu B. Effects of electro-acupuncture on ovarian P450arom, P450c17α and mRNA expression induced by letrozole in PCOS rats. PLoS One, 2013, 8(11): e79382.

    Google Scholar 

  19. Leonhardt H, Hellström M, Gull B, Lind AK, Nilsson L, Janson PO, Stener-Victorin E. Serum anti-Mullerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial. Acta Obstet Gynecol Scand, 2015, 94(3): 279–287.

    Article  PubMed  Google Scholar 

  20. Kafali H, Iriadam M, Ozardali I, Demir N. Letrozoleinduced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res, 2004, 35(2): 103–108.

    Article  CAS  PubMed  Google Scholar 

  21. Patel S. Disruption of aromatase homeostasis as the cause of a multiplicity of ailments: a comprehensive review. J Steroid Biochem Mol Biol, 2017, 168: 19–25.

    Article  CAS  PubMed  Google Scholar 

  22. Chen H, Guo JH, Lu YC, Ding GL, Yu MK, Tsang LL, Fok KL, Liu XM, Zhang XH, Chung YW, Huang P, Huang H, Chan HC. Impaired CFTR-dependent amplification of FSH-stimulated estrogen production in cystic fibrosis and PCOS. J Clin Endocrinol Metab, 2012, 97(3): 923–932.

    Article  CAS  PubMed  Google Scholar 

  23. Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, Stener-Victorin E, Fauser BC, Norman RJ, Teede H. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update, 2016, 22(6): 687–708.

    Article  PubMed  Google Scholar 

  24. Homburg R, Crawford G. The role of AMH in anovulation associated with PCOS: a hypothesis. Hum Reprod, 2014, 29(6): 1117–1121.

    Article  CAS  PubMed  Google Scholar 

  25. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. The Lancet, 2007, 370(9588): 685–697.

    Article  CAS  Google Scholar 

  26. Dewailly D, Catteau-Jonard S, Reyss AC, Maunoury-Lefebvre C, Poncelet E, Pigny P. The excess in 2–5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome. Hum Reprod, 2007, 22(6): 1562–1566.

    Article  PubMed  Google Scholar 

  27. Catteau-Jonard S, Dewailly D. Pathophysiology of polycystic ovary syndrome: the role of hyperandrogenism. Front Horm Res, 2013, 40: 22–27.

    Article  CAS  PubMed  Google Scholar 

  28. Bhide P, Kulkarni A, Dilgil M, Dhir P, Shah A, Gudi A, Homburg R. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational crosssectional study. Gynecol Endocrinol, 2017, 33(10): 801–806.

    Article  CAS  PubMed  Google Scholar 

  29. Leonhardt H, Hellström M, Gull B, Lind AK, Nilsson L, Janson PO, Stener-Victorin E. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimullerian hormone, free testosterone, and glucose disposal rate. Fertil Steril, 2014, 101(6): 1747–1756.

    Article  CAS  PubMed  Google Scholar 

  30. Stracquadanio M, Ciotta L, Palumbo MA. Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women. Gynecol Endocrinol, 2017, 34(3): 1.

    Google Scholar 

  31. Pradeep PK, Li X, Peegel H, Menon KM. Dihydrotestosterone inhibits granulosa cell proliferation by decreasing the cyclin D2 mRNA expression and cell cycle arrest at G1 phase. Endocrinology, 2002, 143(8): 2930–2935.

    Article  CAS  PubMed  Google Scholar 

  32. Bani Mohammad M, Majdi Seghinsara A. Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH. Asian Pac J Cancer Prev, 2017, 18(1): 17–21.

    PubMed  Google Scholar 

  33. Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY. Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction. Hum Reprod, 2010, 25(10): 2597–2604.

    Article  CAS  PubMed  Google Scholar 

  34. Li QQ, Zhong WQ, Zhang J, Zeng RY, Feng SL. Clinical observation of acupuncture plus auricular point sticking for polycystic ovary syndrome. Shanghai Zhenjiu Zazhi, 2017, 36(8): 895–899.

    Google Scholar 

  35. Monica Brauer M, Smith PG. Estrogen and female reproductive tract innervation: cellular and molecular mechanisms of autonomic neuroplasticity. Auton Neurosci, 2015, 187: 1–17.

    Article  CAS  PubMed  Google Scholar 

  36. Uchida S, Kagitani F. Autonomic nervous regulation of ovarian function by noxious somatic afferent stimulation. J Physiol Sci, 2015, 65(1): 1–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by National Basic Research Program of China (973 Program, 国家重点基础研究发展 计划项目, No. 2015CB554500); Research Project of Autonomous Selection of China Academy of Traditional Chinese Medicine (中国中医科学院自主选题研究项目, No. ZZKF08002); Project of Shanghai Municipal Commission of Health and Family Planning (上海市卫生 和计划生育委员会科研课题, No. 201840307); Shanghai Academic Community of Leading Talents in Chinese Medicine ( 上海市中医药领军人才项目, No. ZYSNXD-RC-LJRC). We are grateful for the strong support of JRDUN Biotechnology (Shanghai) Co., Ltd.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yin Shi  (施茵) or Liang Li  (李亮).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, J., Sun, Y., Sun, J. et al. Effect of electroacupuncture on anti-Mullerian hormone expression in rats with polycystic ovarian syndrome. J. Acupunct. Tuina. Sci. 17, 80–88 (2019). https://doi.org/10.1007/s11726-019-1094-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11726-019-1094-y

Keywords

关键词

中图分类号

文献标志码

Navigation